Aandeel 8189 TIANJIN TEDA BIOMEDICAL ENGINEERING COMPANY LIMITED
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Tianjin TEDA Biomedical Engineering Company Limited

Aandelen

8189

CNE1000004H7

Beurs gesloten - Hong Kong S.E.
Andere beurzen
 10:08:06 30-04-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
0,075 HKD 0,00% Intraday-grafiek van Tianjin TEDA Biomedical Engineering Company Limited -10,71% -15,73%
28/03 Tianjin TEDA Biomedical Engineering Company Limited rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023 CI
28/03 Tianjin TEDA Biomedical Engineering Company Limited kondigt ontslag aan van de heer Li Xudong als onafhankelijk niet-uitvoerend bestuurder en voorzitter van het auditcomité CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Tianjin TEDA Biomedical Engineering Company Limited Announces Resignation of Mr. Li Xudong as Independent Non-Executive Director and Chairman of the Audit Committee
An undisclosed buyer agreed to acquire an unknown stake in Shanghai Weidi Network Technology Company Limited from Tianjin TEDA Biomedical Engineering Company Limited
Tianjin TEDA Biomedical Engineering Company Limited Announces Chief Executive Officer Changes
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Tianjin TEDA Biomedical Engineering Company Limited Announces Change of Principal Place of Business in Hong Kong
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022
Tianjin TEDA Biomedical Engineering Company Limited Announces Mr. Hao Zhihui Will Retire as an Executive Director
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Tianjin Teda Biomedical Engineering Company Limited Announces Executive Changes
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Tianjin TEDA Biomedical Engineering Company Limitedcompleted the acquisition of Shanghai Weidi Network Technology Company from three shareholders.
Tianjin TEDA Biomedical Engineering Company Limited entered into the Equity Transfer Agreement to acquire Shanghai Weidi Network Technology Company from three shareholders for CNY12.8 million.
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021
Tianjin Teda Biomedical Engineering Company Limited Announces Delay in Publication and Despatch of Annual Report for the Year
Tianjin TEDA Biomedical Engineering Company Limited Approves Appointment of Mr. Zhao Zhiyou as the Independent Supervisor
Wang Shuxin entered into the Equity Transfer Agreement to acquire 30.2653% stake in Tianjin Alpha Healthcare Products Co., Ltd. from Tianjin TEDA Biomedical Engineering Company Limited for CNY 10.86 million.
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers 8189
  4. Nieuws Tianjin TEDA Biomedical Engineering Company Limited
  5. Andere talen